QR-Code

Dalbavancin Use in Bone and Joint Infections

Background: Dalbavancin (DAL) off-label use for treating bone and joint infections has increased especially as long-term intravenous access is not needed. Little is known about the effectiveness and safety of its use. Methods: This retrospective, single-center, descriptive study included adults trea...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Liam P. Alderson, BS, Srivani Sanikommu, MD, Simon C. Mears, MD, PhD, C. Lowry Barnes, MD, Benjamin M. Stronach, MD, Jeffrey B. Stambough, MD, Jennifer McDonald, RPh, Traci Motes, APRN, Brett Bailey, PharmD, Ryan K. Dare, MD
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2024-12-01
Schriftenreihe:Arthroplasty Today
Schlagworte:
Dalbavancin (DAL)
Peri-prosthetic joint infection (PJI)
Osteomyelitis
Methicillin-resistant Staphylococcus aureus (MRSA)
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2352344124001900
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge